Eleven Therapeutics Raises $22m Series Seed

08.26.2022 | Avi

In the News

2/8/2022

London, UK

Round includes $9 Million from the Bill & Melinda Gates Foundation, aimed at ushering in the next generation of RNAi therapeutics

https://medium.com/@eleventx/eleven-therapeutics-announces-22-million-in-seed-funding-7a51cbc1bce7

Related Resources

Sensi.ai’s $100M Journey: Vertical AI Shaping the Future of Care Intelligence

The world’s population is aging rapidly yet most seniors want to remain at home rather than move into retirement facilities . Yet, 89 % of home‑care providers have had to turn away new clients because they cannot find caregivers. This “care gap” is exactly the kind of challenge that vertical AI industry‑specific systems can potentially solve, so Entrée Capital invested in Sensi.ai to solve these challenges.

Blocks Raises $10m Seed to Reimagine How Teams Work with AI

Congrats to portfolio co Blocks on coming out of stealth and announcing its $10M Seed round!

Figma Acquires Weavy — A Defining Moment for Creative AI and Israeli Innovation

We are incredibly proud to share that Figma has acquired Weavy, only nine months after Entrée Capital led the company’s Seed financing. It’s an amazing outcome – visionary founders, a breakthrough product in a rapidly shifting creative landscape, and the continued strength and resilience of Israeli technology on the global stage.